Sun Pharmaceutical Industries reports marginal rise in Q2 consolidated net profit

06 Nov 2025 Evaluate

Sun Pharmaceutical Industries has reported result for second quarter ended September 30, 2025 (Q2FY26).

The company has reported 32.70% fall in its net profit at Rs 564.22 crore for the quarter ended September 30, 2025 as compared to Rs 838.37 crore for the same quarter in the previous year. The total income of the company decreased by 11.44% at Rs 4,620.90 crore for Q2FY26 as compared to Rs 5,217.68 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 2.56% rise in its net profit at Rs 3,117.95 crore for Q2FY26 as compared to Rs 3,040.16 crore for the same quarter in the previous year. The total income of the company increased by 9.55% at Rs 14,948.23 crore for Q2FY26 as compared to Rs 13,645.39 crore for the corresponding quarter previous year.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×